health data are reported by self-identified race. 1 Recent studies have provided compelling evidence in support of the notion that PCa health disparities result from the interplay of multiple factors, including biological/genetic factors. [11] [12] [13] [14] For instance, several recent studies have reported genomic differences between AA men with PCa and Caucasian or European American (EA) with PCa, suggesting a potential role for biological mediators in driving PCa mortality disparities. [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] Understanding how these mediators contribute to increased PCa mortality in AA men requires mechanistic functional studies in preclinical cellular and animal models of PCa.
Given the inherent difficulties in conducting mechanistic studies in primary PCa cells, including transfection issues and high degree of molecular variability as these primary cells propagate in vitro, [28] [29] [30] [31] it is essential to have available a well-characterized, racially diverse, patient-derived cohort of immortalized cell lines representing different stages of PCa. Unfortunately, there is currently a lack of racial diversity in the human PCa cell lines that are commercially available for research.
While there is over a dozen of commercially available human prostate cell lines of European ancestry that are representative of various prostate phenotypes such as normal and different PCa stages, there are only three cell lines identified as having African ancestry (Table 1) . [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] This limits the scope of in vitro studies addressing mechanistic events involving potential biological factors associated with PCa health disparities.
Research into molecular and genetic mechanisms underlying PCa mortality disparities will be greatly advanced by the availability of preclinical cellular models of AA prostate tumors representing different stages of the disease. 46 There is a growing awareness of the need for biospecimens from AA populations that could be used for biomedical research, and an effort has been made by PCa researchers to develop AA prostate cell lines for cancer health disparities research. [46] [47] [48] [49] [50] [51] For example, RC-77N/E and RC-77T/E is a pair of African American prostate cell lines that were recently developed by one of the coauthors in this study (C Yates), and are available for research upon request. 46 While we recognize that the use of cell lines in cancer research has limitations, and that determinants of PCa health disparities may not be conclusively identified via in vitro studies, the use of racially diverse PCa cell lines in mechanistic studies may provide important clues into contributing biological mediators.
The 22Rv1 human prostatic carcinoma cell line was derived from a xenograft of CWR22R cells serially propagated in mice after castration-induced regression. 32, 52 A number of biological characteristics were specified when 22Rv1 was derived, including epithelial lineage, DNA content, and cytogenetic data. 32 The donor patient clinical information provided for the parental cell line CWR22R was the diagnosis of Stage D primary prostatic carcinoma with Gleason score of 9 advanced to osseous metastasis. 52 While conducting studies using 22Rv1 cells we noticed that no racial identifier was ever released for this cell line or the parental CWR22R, and no subsequent DNA ancestry analysis has been conducted to identify its ethnicity. 32, 52 Recently, the National Institutes of Health established guidelines concerning the authentication of key biological resources, including cell lines, in order to ensure the identity and validity of the resource. 53 This authentication applies to racial identity if the cell line is being used in biological studies relevant to cancer health disparities. 
| Selection of ancestry informative marker (AIM) SNPs
We used 29 Ancestry Informative Marker (AIM) SNPs validated in a previous study involving determination of admixture proportions in human continental populations. 54 We selected the smallest subset of 24 AIMs and 5 additional SNPs from the previous study, as a cost-and time-effective strategy, to determine the ancestry of the abovementioned PCa cell lines of interest. All the 29 selected SNPs exhibited large allele frequency differences between four continental populations-AFR, EUR, Amer-Indian (AMI), and East Asian (EAS) in the previous study. 54 We confirmed the allele frequency differences between these ancestral groups for each of the 29 AIM SNPs using the NCBI dbSNP database (https://www.ncbi.nlm.nih.gov/snp).
| SNP genotyping
SNP genotyping was done using the Fluidigm Biomark HD system (South San Francisco, CA) at the UCLA Genotyping core facility.
SNPtype™ assays and reagents for each of the SNPs were purchased from Fluidigm. DNA samples and assays were loaded onto GT 96*96
Dynamic array and processed per Fluidigm protocol. The genotyping calls were made using Fluidigm SNP genotyping software. Each DNA sample was analyzed in triplicate to ensure accuracy. After the determination of true K, STRUCTURE was run three times, without any prior population assignment for an admixture population using 100 000 as the length of the Burnin period and 500 000 as the number of MCMC replicates after the burnins, for K = 2 and K = 3. The missing value was represented as −9, the maximum value of ALPHA 3 | RESULTS
| Informative ancestry markers for distinguishing ancestral proportions
An initial subset of 24 AIM SNPs was selected from a validated larger set of 128 SNPs previously identified to define critical genome candidate regions and used to characterize samples from diverse population groups (Table 2) . 54 This subset of 24 AIMs contained specific SNPs capable of distinguishing the following four continent populations: EUR, AFR, AMI, and EAS. 54 Five additional AIMs from the validated larger set of 128 AIMs were added to the smaller subset of 24
AIMs, bringing our total quantity of AIMs used for DNA ancestry analysis to 29 ( Table 2 ).
| Determination of ancestral proportions of prostate cancer cell lines
Each PCa cell line analyzed in our study possessed heterogeneous ancestral proportions ( Figure 1 and 
| DISCUSSION
In concordance with recent NIH guidelines requiring authentication of cell lines, this study sought to determine the racial identity of 22Rv1
PCa cells since racial classification/ethnicity for this cell line has never been reported to ATCC or previously published. 32, 52, 53 It has been our experience in personal communication with other groups that 22Rv1 is widely considered as a EA PCa cell line, and we had no reason to explore this assumption until we began incorporating various EA and AA cell lines in our studies. 27, 59, 60 We initially conducted a thorough literature search and contacted ATCC to determine if there was any indication of racial identification for either 22Rv1 or its parental cell line CWR22R. In addition, we communicated with key authors of the initial reports on the characterization of both cell lines to determine if there was any racial identification linked to the tumor biospecimen from which these cell lines were derived. 32, 52 Unfortunately, these efforts did not provide any indication as to the racial classification of these cell lines. This lack of information prompted us to conduct DNA ancestry analysis on 22Rv1 cells and provide this information to the PCa research community and the scientific community at large. We felt this was a very important issue given the need for a comprehensive panel of racially diverse patient-derived cell lines for mechanistic studies on potential biological mediators of PCa mortality disparities.
SNP genotyping and subsequent DNA ancestry analysis were chosen as appropriate methods to determine the ancestry for 22Rv1.
Other investigators have shown that differences in allele frequencies can be used to identify continental population groups. 61, 62 This is because several studies have demonstrated that large differences in allele frequencies between two or more continental populations can be attributed to many individual SNPs distributed throughout the genome. [63] [64] [65] [66] [67] In this study, 29 AIM SNPs were chosen from a validated larger set of 128 SNPs previously identified by others to define critical genome candidate regions and used to characterize samples from diverse population groups. 54 Differences in population structure were addressed by extending genetic associations to minority groups that include extensive admixture between continents. 54 This genetic association extension was essential to evaluate ethnic disparities in disease risk among multiethnic and admixed populations as a large number of whole genome association studies have evaluated populations of predominantly EUR ancestry. 54 Our analysis revealed that the 22Rv1 PCa cell line carries AFR genetic ancestry, with almost equal proportions for AFR and EUR ancestry (41% and 42%, respectively). While this study authenticates the previously reported racial identification of several PCa cell lines (PC3, DU145, MDA-PC-2b, and RC-77T/E), it establishes for the first time the ancestral composition of 22Rv1. Because 22Rv1 was derived from a xenograft of CWR22R cells which was serially propagated in mice, 32, 52 it would be appropriate to also assign this mixed ancestral racial classification to the CWR22R cell line. The implications of 22Rv1 and CWR22R carrying AFR genetic ancestry are far reaching as genetic factors associated with AFR ancestry have been recently linked to prostate tumor aggressive properties. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] Further studies are needed to determine if these cell lines carry any of these factors. In addition, our findings open the door for closely examining previous studies using 22Rv1 and CWR22R cells under the new perspective that these cell lines carry almost equal proportions of AFR and EUR genetic ancestry.
We suggest that 22Rv1 and CWR22R can be be added to the current roster of PCa cell lines that are classified as Black, AA, or carry . DNA samples were analyzed in triplicate to ensure accuracy. The bar plot shown in this figure was generated using STRUCTURE for visualization of the ancestral proportion in each sample. Subsequent analysis of population substructure was also conducted using STRUCTURE, a model-based clustering software able to detect the underlying genetic population among a set of individuals genotyped at multiple markers with the help of a Bayesian approach (http://pritch.bsd.uchicago.edu/software/ structure2). 57 Using STRUCTURE, we were able to compute the proportion of the genome of the cell lines originating from each inferred population. Blue, AFR ancestry; Green, AMI ancestry; Red, EUR ancestry 
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